Shin-E Wang

709 total citations
11 papers, 162 citations indexed

About

Shin-E Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Shin-E Wang has authored 11 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Shin-E Wang's work include Pancreatic and Hepatic Oncology Research (8 papers), Renal cell carcinoma treatment (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Shin-E Wang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Renal cell carcinoma treatment (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Shin-E Wang collaborates with scholars based in Taiwan and Italy. Shin-E Wang's co-authors include Yi‐Ming Shyr, Tien-Hua Chen, Cheng-Hsi Su, Chew-Wun Wu, Wing-Yiu Lui, Chen-Hsen Lee, Ying‐Ju Kuo, Bor‐Uei Shyr, Shih‐Chin Chen and Shih‐Ching Chang and has published in prestigious journals such as Oncotarget, Surgical Endoscopy and Cancers.

In The Last Decade

Shin-E Wang

11 papers receiving 157 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shin-E Wang Taiwan 7 111 65 59 46 31 11 162
Anna Malpaga Italy 6 122 1.1× 53 0.8× 30 0.5× 64 1.4× 34 1.1× 8 124
Marina Morais Portugal 7 44 0.4× 75 1.2× 49 0.8× 23 0.5× 11 0.4× 20 135
Renquan Zhang China 7 114 1.0× 224 3.4× 173 2.9× 26 0.6× 19 0.6× 16 272
Sarah Powell‐Brett United Kingdom 8 139 1.3× 101 1.6× 33 0.6× 25 0.5× 6 0.2× 31 195
Raneem Albazaz United Kingdom 8 84 0.8× 129 2.0× 70 1.2× 39 0.8× 5 0.2× 18 239
Frank Bonnetain France 5 197 1.8× 85 1.3× 39 0.7× 70 1.5× 53 1.7× 9 213
Felice Granato United Kingdom 9 66 0.6× 59 0.9× 187 3.2× 29 0.6× 46 1.5× 29 249
Giovanna Di Meo Italy 10 63 0.6× 134 2.1× 48 0.8× 23 0.5× 7 0.2× 22 249
Prerna Guleria India 8 55 0.5× 53 0.8× 30 0.5× 29 0.6× 32 1.0× 25 149
M. G. Camboni Italy 6 227 2.0× 188 2.9× 92 1.6× 118 2.6× 31 1.0× 10 287

Countries citing papers authored by Shin-E Wang

Since Specialization
Citations

This map shows the geographic impact of Shin-E Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin-E Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin-E Wang more than expected).

Fields of papers citing papers by Shin-E Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shin-E Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin-E Wang. The network helps show where Shin-E Wang may publish in the future.

Co-authorship network of co-authors of Shin-E Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shin-E Wang. A scholar is included among the top collaborators of Shin-E Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shin-E Wang. Shin-E Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chen, Chian‐Feng, Shin-E Wang, Shih‐Chin Chen, et al.. (2024). Andrographolide suppresses the malignancy of pancreatic cancer via alleviating DNMT3B-dependent repression of tumor suppressor gene ZNF382. Phytomedicine. 132. 155860–155860. 3 indexed citations
2.
3.
Wang, Shin-E, et al.. (2021). Circulating Cell-Free DNA in Pancreatic Head Adenocarcinoma Undergoing Pancreaticoduodenectomy. Pancreas. 50(2). 214–218. 11 indexed citations
4.
Shyr, Bor‐Uei, et al.. (2021). Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer. Cancers. 13(10). 2313–2313. 2 indexed citations
5.
Lau, Ling-Ing, et al.. (2017). Acute macular edema and peripapillary soft exudate after pancreas transplantation with accelerated progression of diabetic retinopathy. Journal of the Chinese Medical Association. 80(5). 319–325. 6 indexed citations
6.
Chen, Jen‐Kun, Shin-E Wang, Yi‐Ming Shyr, et al.. (2016). Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis. Oncotarget. 7(34). 55437–55448. 20 indexed citations
7.
Wang, Shin-E, Yi‐Ming Shyr, Cheng-Hsi Su, Tien-Hua Chen, & Chew-Wun Wu. (2012). Palliative Pancreaticoduodenectomy in Pancreatic and Periampullary Adenocarcinomas. Pancreas. 41(6). 882–887. 9 indexed citations
8.
Wang, Shin-E, et al.. (2011). Resection for Secondary Malignancy of the Pancreas. Pancreas. 41(1). 121–129. 29 indexed citations
9.
Wang, Shin-E, Cheng-Hsi Su, Ying‐Ju Kuo, et al.. (2010). Comparison of Functional and Nonfunctional Neuroendocrine Tumors in the Pancreas and Peripancreatic Region. Pancreas. 40(2). 253–259. 30 indexed citations
10.
Wang, Shin-E, Yi‐Ming Shyr, Tien-Hua Chen, et al.. (2009). Risk Factors for Post-Pancreaticoduodenectomy Bleeding and Finding an Innovative Approach to Treatment. Digestive Surgery. 26(4). 297–305. 30 indexed citations
11.
Wang, Shin-E, Yi-Fang Tsai, Cheng-Hsi Su, et al.. (2006). Retroperitoneal Bronchogenic Cyst Mimicking Pancreatic Cystic Lesion. Journal of the Chinese Medical Association. 69(11). 538–542. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026